Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. J.H.M. (Anke) van den Berg

Speerpunten

Ik ben klinisch moleculair bioloog bij de Afdeling pathologie van het UMCG en onderzoeker in het “Stem cells, Ageing, Leukemia and Lymphoma” (SALL) programma van het Kanker Research Centrum Groningen. In mijn onderzoek focus ik op de moleculaire pathogenese van B cel lymfomen, waarbij het onderzoeken van genomische afwijkingen, genetische susceptibiliteit, de rol van niet coderende RNAs en de interactie tussen tumorcellen en de infiltrerende cellen centraal staan.

Publicaties

Disturbed antigen presentation in classical Hodgkin Lymphoma; implications for immune checkpoint inhibitor therapy

ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma

Long noncoding RNAs as a novel component of the Myc transcriptional network

miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis

Long Noncoding RNA Expression Profiling in Normal B-Cell Subsets and Hodgkin Lymphoma Reveals Hodgkin and Reed-Sternberg Cell Specific Long Noncoding RNAs

Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors

Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC

Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma

WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage

Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphoma

Lees meer

Pers/media

College